Houston Republic

On April 21, Congresswoman Lizzie Fletcher (TX-07) released the following statement after the U.S. Supreme Court’s decision in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA).  Mifepristone is a safe and effective medication used in abortion care, including miscarriage treatment, originally approved for use more than 20 years ago.  It is used in more than half of all abortions in states where abortion remains legal. 

“The Supreme Court has made the appropriate decision to stay the prior court’s ruling.  Today, American women in many states can be reassured knowing that access to medication abortion remains intact in states where it remains legal.  I will continue to defend the FDA’s scientific judgement and to fight for every woman across our country to have access to safe and effective reproductive health care.” 

Congresswoman Lizzie Fletcher is a leader in the Congressional Pro-Choice Caucus and has led several efforts to protect access to abortion.  After a Texas Judge banned abortion medication across the country, she introduced the Protecting Reproductive Freedom Act, H.R. 2573, with Congressman Pat Ryan (NY-18) to reaffirm that the abortion pill was appropriately approved by the FDA. 

She is the lead House sponsor of a bill to protect the right to travel between states to obtain an abortion, the Ensuring Women’s Right to Reproductive Freedom Act, H.R. 782, which passed the House in the last Congress, and which she reintroduced this year.  She has also introduced legislation challenging the bounty system created in Texas Senate Bill 8.  Congresswoman Fletcher was an original cosponsor of the Women’s Health Protection Act, H.R. 12, which establishes a statutory federal right to abortion free from medically unnecessary restrictions. 

 

Original source can be found here.